Suchergebnisse - "Remission Induction"

PubPharm (354)

31

A Phase II study of combination chemotherapy including Bortezomib in pediatric patients with relapsed acute lymphoblastic leukemia (Investigator-initiated clinical trial) : A Phase II study of combination chemotherapy including Bortezomib in pediatric patients with relapsed acute lymphoblastic leukemia (Investigator-initiated clinical trial) - Bortezomib for relapsed ALL (BZM-ALL-2)

enthalten in: WHO International Clinical Trials Registry Platform | 2022

32

A Phase II study of combination chemotherapy including Bortezomib in pediatric patients with relapsed acute lymphoblastic leukemia (Investigator-initiated clinical trial) : A Phase II study of combination chemotherapy including Bortezomib in pediatric patients with relapsed acute lymphoblastic leukemia (Investigator-initiated clinical trial) - Bortezomib for relapsed ALL (BZM-ALL-2)

enthalten in: WHO International Clinical Trials Registry Platform | 2022

33

Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry

enthalten in: Clinical rheumatology | 2022

von Bodur, H. | Yurdakul, F. | Ataman, S. | +12

34

Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry

enthalten in: Clinical rheumatology | 2022

von Bodur, H. | Yurdakul, F. | Ataman, S. | +12

35

Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry

enthalten in: Clinical rheumatology | 2022

von Bodur, H. | Yurdakul, F. | Ataman, S. | +12

36

Treating-to-target in rheumatology : Theory and practice

enthalten in: Best practice & research. Clinical rheumatology | 2022

von Duarte, C. | Ferreira, R. | Santos, E. | +1

37

Measurable Residual Disease in High-Risk Acute Myeloid Leukemia

enthalten in: Cancers | 2022

von Cluzeau, T. | Lemoli, R. | McCloskey, J. | +1

38

Use of topical anti-inflammatory and antineoplastic agents in the treatment of young-aged actinic cheilitis : A systematic review

enthalten in: Journal of cosmetic dermatology | 2022

von Medeiros, C. | de França, G. | Lima, J. | +3

39

Reduced Dose Intensity of Daunorubicin During Remission Induction for Low-Risk Patients With Acute Lymphoblastic Leukemia : A Retrospective Cohort Study of the Chinese Children's Cancer Group

enthalten in: Frontiers in oncology | 2022

von Zhuang, Y. | Wu, K. | Zhu, X. | +20

40

Therapie-Update der ANCA-assoziierten Vaskulitiden: Granulomatose mit Polyangiitis und Mikroskopische Polyangiitis

enthalten in: Zeitschrift für Rheumatologie | 2022

von Holle, J. | Hellmich, B. | Moosig, F.